Associate Professor Tey Hong Liang is a clinician-scientist, innovator, and entrepreneur. He serves as Clinical Director of the Centre for MedTech and Innovation at the National Healthcare Group, Clinical Co-Director of the Skin Research Programme at the Lee Kong Chian School of Medicine, Nanyang Technological University, and Senior Consultant Dermatologist at the National Skin Centre.

A National Medical Research Council Senior Clinician Scientist awardee, A/Prof Tey is ranked among the world’s top 2% of scientists (by Stanford university & Elsevier) and top 0.67% of scholars globally (by ScholarGPS). His work has led to the development of over 30 healthcare products that have been commercialised in > 20 countries across four continents.

His contributions to healthcare have been recognised through multiple awards, including the Exemplary Innovator at the Singapore Public Sector Transformation Awards and the National Healthcare Group Outstanding Citizenship Award.

Hywel trained in London at King’s College and St John’s Dermatology Centre where he developed diagnostic criteria for eczema that are now used worldwide. Hywel joined Nottingham University in 1994 where he also worked as a paediatric dermatologist. He founded the Cochrane Skin Group in 1996, the UK Dermatology Clinical Trials Network in 2002, and the Harmonising Outcome Measure for Eczema (HOME) in 2008. He is the second most cited (Scholar) clinical dermatologist globally with 200,000+ citations and 660 publications. Hywel directed the NIHR Health Technology Assessment Programme 2016-2020 and advised the Department of Health on COVID-19 research oversight 2020-2021. Hywel has had lifelong eczema and is a champion of patient/public involvement in research. He  is holder of the Sir Archibald Gray medal, an NIHR senior investigator emeritus and fellow of the Academy of Medical Sciences and received an OBE in 2021 for services to medical research.